Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984436 · ClinicalTrials.gov registry record
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 1,572
- Enrollment target
NCT02984436: Completed study, sponsored by University of Florida.
NCT02984436 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 1,572 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02984436 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 1,572 participants
- Enrollment target
Study Summary
This is a prospective observational cohort study of ED patients with acute chest pain or other symptoms suggestive of ACS. Blood samples will be collected from study participants for High-Sensitivity Cardiac Troponin T (hs-cTnT) analysis. Results from hs-cTnT will be used for research purposes only. Providers will be blinded to results and participants will be treated by their healthcare providers per the standard of care. Participants will have 30 and 90 day phone follow-ups to ascertain study outcomes.
Primary Outcome
The research team will obtain two lithium heparin tubes at baseline, 1, 2, and 3 hours for sampling and preparation for shipping to the core laboratory in Maryland for hs-cTnT processing. Providers will be blinded to hs-cTnT results.
Interventions
- PROCEDURE Blood Sample
- BEHAVIORAL HEART Score
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,572 participants |
| Start Date | 2017-01-25 |
| Est. Completion | 2020-09-30 |
What the finished NCT02984436 record still lists
NCT02984436 is an observational study that tracks outcomes without assigning an intervention. Its 1,572 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Blood Sample is the first listed.
NCT02984436 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02984436 about?
NCT02984436 is a clinical study titled "High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification". This is a prospective observational cohort study of ED patients with acute chest pain or other symptoms suggestive of ACS. Blood samples will be collected from study participants for High-Sensitivity Cardiac Troponin T (hs-cTnT) analysis. Results from hs-cTnT will be used for research purposes only....
What is the current status of trial NCT02984436?
This trial is currently completed. The enrollment target is 1,572 participants. The study started on 2017-01-25. Estimated completion is 2020-09-30.
What interventions are being tested in trial NCT02984436?
The interventions under investigation include: Blood Sample (PROCEDURE), HEART Score (BEHAVIORAL).
Who is sponsoring clinical trial NCT02984436?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI